News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Trump's attorneys petitioned the U.S. Supreme Court to set aside an $83.3 million defamation judgment in favor of E. Jean Carroll.
  • Carroll has received nearly $5.63 million from prior awards tied to the case.
  • Total civil awards against Trump in Carroll-related suits now equal $88.3 million.
  • The civil verdicts stem from Trump's denials beginning in 2019 about an alleged 1996 assault.
  • The petition seeks Supreme Court review, escalating the dispute to the high court.
  • The filing preserves appeals and prolongs uncertainty over enforcement of the judgments.

Latest Articles

European gas prices slip as crude weakness and milder demand weigh

European gas prices slip as crude weakness and milder demand weigh

European natural gas benchmarks fell on Monday, tracking a drop in crude oil after reports the U.S. considered a temporary waiver on sanctions for Iranian crude. Prices eased as some demand was tempered by warmer temperatures and strong renewable generation, while many gas contracts remained sensitive to movements in oil markets.

AppLovin: Buy the Cash-Flow Story While the Market Tilts Skeptical

AppLovin: Buy the Cash-Flow Story While the Market Tilts Skeptical

AppLovin reported consecutive quarters of high-teens-to-double-digit top-line growth and exceptionally strong operating leverage. With Q1 revenue accelerating to $1.84 billion (+59% YoY) and industry-leading adjusted margins, AppLovin is producing material free cash flow that is poorly reflected in the current narrative. This trade idea lays out a …

Trump Says He Wishes He Had Secured a Bigger Government Stake in Intel

Trump Says He Wishes He Had Secured a Bigger Government Stake in Intel

President Donald Trump told Fortune he had asked Intel CEO Lip-Bu Tan for a 10% stake for free when the U.S. government converted federal support into equity last year. Trump said he "should have asked for more" as Intel's stock has climbed more than 300% since the government took a 9.9% holding. The equity came from converting CHIPS Act grants and…

POET Technologies Announces Closing of US$400 Million Investment

POET Technologies Announces Closing of US$400 Million Investment

POET Technologies announced the closing of a $400 million investment through a registered direct offering, issuing over 19 million shares and warrants at a premium price. The funds will be used to significantly expand manufacturing capacity, support corporate development including acquisitions, accelerate R&D, and grow operations in Asia. This stra…

Regeneron Stock Plummets After Melanoma Drug Misses Primary Endpoint

Regeneron Stock Plummets After Melanoma Drug Misses Primary Endpoint

Regeneron shares fell sharply after its experimental combination of fianlimab and cemiplimab failed to meet the main goal in a late-stage trial for advanced melanoma. The company faces mounting pipeline scrutiny following other recent clinical and regulatory setbacks, even as it pursues a separate head-to-head study and a new partnership with Parab…

CBAK Energy Reports First Quarter 2026 Unaudited Financial Results

CBAK Energy Reports First Quarter 2026 Unaudited Financial Results

CBAK Energy Technology reported strong first quarter 2026 results with consolidated net revenues nearly doubling year-over-year to $69.62 million, driven by expanded production capacity and significant growth in light electric vehicles and battery raw materials segments. While revenues surged, gross margins declined due to ramp-up costs and delayed…

Applied Optoelectronics: Why I'm Hanging On Through the Volatility

Applied Optoelectronics: Why I'm Hanging On Through the Volatility

Applied Optoelectronics (AAOI) has been one of the poster children for the photonics/data-center trade. The stock is volatile and richly valued - but recent hyperscaler orders, a new Texas capacity build, and product wins give me enough conviction to keep a long position with a disciplined stop. This is an actionable trade idea with entry, stops, a…

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures

Royal Philips introduces SmartIQ, a new imaging technology integrated into its Azurion image-guided therapy system designed for coronary procedures. SmartIQ offers improved image quality with over 50% less X-ray radiation dose compared to previous protocols, addressing the critical trade-off in coronary imaging between clarity and radiation exposur…

Supreme Court Lets Stand $194 Million Fraud Award Against Eli Lilly

Supreme Court Lets Stand $194 Million Fraud Award Against Eli Lilly

The US Supreme Court declined to hear Eli Lilly's appeal of a $194 million judgment in a whistleblower suit accusing the drugmaker of understating revenues from wholesalers to reduce Medicaid rebate obligations. The company had sought to overturn the False Claims Act on constitutional grounds but the justices refused to take the case.

Ryanair Chief Warns Prolonged Iran Conflict Could Topple European Carriers

Ryanair Chief Warns Prolonged Iran Conflict Could Topple European Carriers

Ryanair CEO Michael O’Leary cautioned that an extended Iran war and ongoing restrictions in the Strait of Hormuz could force European airlines into collapse. He singled out Wizz Air and Air Baltic as particularly vulnerable, questioned the recoverability of government support, and said Ryanair would consider buying aircraft if carriers sell assets.

Supreme Court Lets Stand $183 Million False Claims Verdict Against Eli Lilly

Supreme Court Lets Stand $183 Million False Claims Verdict Against Eli Lilly

The U.S. Supreme Court refused to hear Eli Lilly’s appeal of a lower-court ruling that affirmed a $183 million judgment under the False Claims Act, leaving intact a verdict that stemmed from a 2014 whistleblower suit alleging improper Medicaid rebates. The decision preserves the operation of the qui tam provisions that let private citizens sue on t…

Regeneron Shares Slide After Phase 3 Melanoma Trial Misses Primary Endpoint

Regeneron Shares Slide After Phase 3 Melanoma Trial Misses Primary Endpoint

Regeneron Pharmaceuticals stock plunged after a Phase 3 study testing fianlimab, a LAG-3 inhibitor, together with cemiplimab failed to achieve statistical significance for its primary endpoint of improved progression-free survival versus pembrolizumab monotherapy in first-line unresectable or metastatic melanoma. The regimen produced a 5.1-month nu…